GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma (Q51768279)

11 April 2018

title

GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma (English)

1 reference

11 April 2018

1 reference

11 April 2018

author name string

David Delaney

1 reference

11 April 2018

Tim C Diss

1 reference

11 April 2018

Nadege Presneau

1 reference

11 April 2018

Sandra Hing

1 reference

11 April 2018

Fitim Berisha

1 reference

11 April 2018

Bernadine D Idowu

1 reference

11 April 2018

P O'Donnell

1 reference

11 April 2018

Roberto Tirabosco

1 reference

11 April 2018

Adrienne M Flanagan

1 reference

11 April 2018

publication date

13 March 2009

1 reference

11 April 2018

published in

Modern Pathology

1 reference

11 April 2018

volume

1 reference

11 April 2018

issue

1 reference

11 April 2018

page(s)

718-724

1 reference

11 April 2018

Syndrome Characterized by Osteitis Fibrosa Disseminata, Areas of Pigmentation and Endocrine Dysfunction, with Precocious Puberty in Females

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

INTRAMUSCULAR MYXOMA; A REVIEW AND FOLLOW-UP STUDY OF 34 CASES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

Intramuscular myxoma--a clinicopathological study of twenty-three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

S100, alpha-smooth muscle actin and cytokeratin 19 immunohistochemistry in odontogenic and soft tissue myxomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Intramuscular myxoma: a clinicopathologic study of 51 cases with emphasis on hypercellular and hypervascular variants

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in Gαs from patients with fibrous dysplasia of bone

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Translocation (9;22)(q22;q12). A recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Low grade fibromyxoid sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Myxoid tumours of soft tissue.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.32

7 January 2021

10.1038/MODPATHOL.2009.32

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018